These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2999673)

  • 1. Comparison of leukotrienes as conjunctival microvascular permeability factors.
    Woodward DF; Ledgard SE
    Ophthalmic Res; 1985; 17(5):318-20. PubMed ID: 2999673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the conjunctival vasopermeability response to leukotrienes and their involvement in immediate hypersensitivity.
    Gary RK; Woodward DF; Nieves AL; Williams LS; Gleason JG; Wasserman MA
    Invest Ophthalmol Vis Sci; 1988 Jan; 29(1):119-26. PubMed ID: 2826360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effects of LTB4 and LTD4 on leukocyte emigration into the guinea pig conjunctiva.
    Spada CS; Woodward DF; Hawley SB; Nieves AL; Williams LS; Feldmann BJ
    Am J Pathol; 1988 Feb; 130(2):354-68. PubMed ID: 2829632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of synthetic leukotrienes on tracheal microvascular permeability.
    Woodward DF; Weichman BM; Gill CA; Wasserman MA
    Prostaglandins; 1983 Jan; 25(1):131-42. PubMed ID: 6302738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukotrienes cause eosinophil emigration into conjunctival tissue.
    Spada CS; Woodward DF; Hawley SB; Nieves AL
    Prostaglandins; 1986 Apr; 31(4):795-809. PubMed ID: 3014611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-dependent differences in the vasopermeability response to intradermal peptidoleukotrienes.
    Woodward DF; Gary RK; Spada CS; Hawley SB; Nieves AL
    J Lipid Mediat; 1989; 1(1):63-73. PubMed ID: 2562432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of LTD4 on conjunctival vasopermeability and blood-aqueous barrier integrity.
    Woodward DF; Ledgard SE
    Invest Ophthalmol Vis Sci; 1985 Apr; 26(4):481-5. PubMed ID: 3980167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An atypical vasopermeability response to leukotrienes in the iris-ciliary body.
    Krauss AH; Woodward DF
    Prostaglandins; 1991 Jun; 41(6):559-70. PubMed ID: 1647045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukotrienes: possible mediators in bronchial asthma.
    Piper PJ
    Eur J Respir Dis Suppl; 1983; 129():45-64. PubMed ID: 6317422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of synthetic leukotrienes on local blood flow and vascular permeability in porcine skin.
    Chan CC; Ford-Hutchinson A
    J Invest Dermatol; 1985 Feb; 84(2):154-7. PubMed ID: 2981933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of bradykinin, histamine, and leukotrienes B4, C4 and D4 on the formation of 6-keto-prostaglandin F1 alpha and thromboxane B2 in hamster lungs.
    Puustinen T; Uotila P
    Prostaglandins Leukot Med; 1983 Dec; 12(4):443-8. PubMed ID: 6322206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cyclooxygenase products in the lung action of leukotrienes A4, B4, C4, D4 and E4.
    Sirois P; Chagnon M; Borgeat P; Vallerand P
    Pharmacology; 1985; 31(4):225-36. PubMed ID: 2997811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4, and LTB4) in human skin.
    Soter NA; Lewis RA; Corey EJ; Austen KF
    J Invest Dermatol; 1983 Feb; 80(2):115-9. PubMed ID: 6296237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of leukotrienes C4, D4, and E4 in the pulmonary and systemic vasculature of sheep.
    Ahmed T; Marchette B; Wasserman M; Wanner A; Yerger L
    Bull Eur Physiopathol Respir; 1986; 22(6):573-80. PubMed ID: 3030470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergent influences of leukotrienes C4, D4, and E4 on mesenteric and renal blood flow.
    Chapnick BM
    Am J Physiol; 1984 Apr; 246(4 Pt 2):H518-24. PubMed ID: 6326595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of leukotriene C4, D4 and E4 in allergic inflammation in rats.
    Ohuchi K; Takahashi C; Watanabe M; Hirasawa N; Suzuki Y; Kudo M; Konishi T; Tsurufuji S
    J Clin Lab Immunol; 1988 Dec; 27(4):171-8. PubMed ID: 2855079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactive effects of peptidoleukotrienes and histamine on microvascular permeability and their involvement in experimental cutaneous and conjunctival immediate hypersensitivity.
    Woodward DF; Nieves AL; Williams LS; Gary RK; Wasserman MA; Gleason JG
    Eur J Pharmacol; 1989 May; 164(2):323-33. PubMed ID: 2759180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wheal reactions in human skin after injection of leukotrienes B4, C4, D4 and E4.
    Juhlin L; Hammarström S
    Prostaglandins Leukot Med; 1983 Aug; 11(4):381-3. PubMed ID: 6312459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukotrienes stimulate initiation of DNA synthesis in cultured arterial smooth muscle cells.
    Palmberg L; Claesson HE; Thyberg J
    J Cell Sci; 1987 Sep; 88 ( Pt 2)():151-9. PubMed ID: 2826508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo pharmacologic profile of ONO-1078: a potent, selective and orally active peptide leukotriene (LT) antagonist.
    Nakagawa N; Obata T; Kobayashi T; Okada Y; Nambu F; Terawaki T; Aishita H
    Jpn J Pharmacol; 1992 Nov; 60(3):217-25. PubMed ID: 1337128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.